金宇生物技术股份有限公司2025年半年度报告摘要

Core Viewpoint - The company, Jinyu Biotechnology Co., Ltd., has announced the repurchase and cancellation of 25,500 shares related to its 2023 employee stock ownership plan due to the departure of three employees who held unvested shares [9][12]. Group 1: Company Overview - Jinyu Biotechnology Co., Ltd. is identified by the stock code 600201 and is referred to as "the company" [2]. - The company ensures the accuracy and completeness of its announcements and reports, taking legal responsibility for any misleading information [3]. Group 2: Financial Data - The repurchase price for the shares is set at 6.23 yuan per share [9]. - The total number of shares to be repurchased is 25,500 shares, corresponding to the unvested equity of the departing employees [12]. Group 3: Important Matters - The board of directors held a meeting on August 19, 2025, where the repurchase proposal was unanimously approved by all participating directors [3]. - The repurchase and cancellation of shares will not have a significant impact on the company's financial performance or operational status [13].